Pietro Spitali

Dystrophin levels as low as 30% are sufficient to avoid muscular dystrophy in the human

Marcella Neri, Silvia Torelli, I. Ugo et al. · Neuromuscular Disorders · 2007 · 166 citations

Medicine, Neurology, Neuromuscular Disorders +7

Reduced cerebral gray matter and altered white matter in boys with <scp>D</scp>uchenne muscular dystrophy

N. Doorenweerd, C.S.M. Straathof, Eve M. Dumas et al. · Annals of Neurology · 2014 · 124 citations · Full text

Medicine, Neurology, Neuroscience +17

Affinity proteomics within rare diseases: a BIO‐NMD study for blood biomarkers of muscular dystrophies

Burcu Ayoglu, Amina Chaouch, Hanns Lochmüller et al. · EMBO Molecular Medicine · 2014 · 116 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Fibronectin is a serum biomarker for <scp>D</scp>uchenne muscular dystrophy

F. Cynthia Martin, Monika Hiller, Pietro Spitali et al. · PROTEOMICS - CLINICAL APPLICATIONS · 2014 · 100 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing<i>SPP1</i>and<i>LTBP4</i>variants

J.C. van den Bergen, Monika Hiller, Stefan Böhringer et al. · Journal of Neurology Neurosurgery & Psychiatry · 2014 · 99 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17